Boost: Celebrity fans include actress Rebel Wilson
Pharma giant Novo Nordisk will reveal the booming demand for its weight loss drugs this week.
The Danish firm’s revenues have surged thanks to an explosion in popularity for its diabetes and obesity drugs Ozempic and Wegovy.
Analysts estimate it will report sales of £7.7billion between April and June on Wednesday. They were £3.9billion for the same quarter last year.
Wegovy is an injection that tricks the body into thinking it is full. It is available on the NHS but is particularly popular in the US. Celebrity fans include actress Rebel Wilson.
Novo Nordisk is now worth £210billion.
Shares have risen 64 per cent over the past year.
DIY INVESTING PLATFORMS
AJ Bell
AJ Bell
Easy investing and ready-made portfolios
Hargreaves Lansdown
Hargreaves Lansdown
Free fund dealing and investment ideas
interactive investor
interactive investor
Flat-fee investing from £4.99 per month
Saxo
Saxo
Get £200 back in trading fees
Trading 212
Trading 212
Free dealing and no account fee
Affiliate links: If you take out a product This is Money may earn a commission. These deals are chosen by our editorial team, as we think they are worth highlighting. This does not affect our editorial independence.
Compare the best investing account for you
***
Read more at DailyMail.co.uk